Cancer Science & Therapy

Brain tumors remain a significant challenge in oncology, with high morbidity and mortality rates. Recent advancements in the understanding of tumor biology and technological innovations have led to the development of novel therapeutic strategies. This comprehensive review examines the latest emerging therapies in brain tumor treatment, including immunotherapy, precision medicine, and advanced surgical techniques. We discuss the mechanisms, efficacy, and potential of these therapies, as well as their integration into current clinical practice. By analysing recent clinical trials and research findings, this review aims to provide a thorough understanding of the current landscape and future directions in brain tumor treatment. Traditional treatment modalities, such as surgery, radiotherapy, and chemotherapy, often yield limited success and can be associated with significant side effects. However, recent advances in molecular biology, immunology, and medical technology have paved the way for novel therapeutic approaches. This review aims to provide an in-depth analysis of emerging therapies for brain tumors, highlighting their mechanisms of action, clinical efficacy, and potential to improve patient outcomes.

Artificial Intelligence (AI) has emerged as a transformative technology in the field of oncology, particularly in the treatment of brain tumors. This comprehensive review explores the integration of AI into brain tumor treatment plans, emphasizing its role in improving diagnostic accuracy, treatment planning, and patient outcomes. By analyzing recent advancements and applications of machine learning algorithms, neural networks, and data analytics, this review highlights the potential of AI to revolutionize the management of brain tumors. The discussion addresses the challenges and ethical considerations associated with AI implementation in clinical settings, and the conclusion outlines future directions for research and clinical practice.

The treatment of brain tumors, particularly glioblastomas, remains a formidable challenge due to the development of resistance to conventional therapies such as surgery, radiotherapy, and chemotherapy. This review examines the underlying mechanisms of therapeutic resistance in brain tumors and explores innovative strategies to overcome these obstacles. We highlight advances in molecular biology, immunotherapy, precision medicine, and combination therapies that offer new hope for enhancing treatment efficacy. By analyzing recent research and clinical trials, this review provides insights into current approaches to counteract resistance and discusses future directions for research and clinical practice.

Genetic screening has undergone a profound transformation in the genomic era, fueled by advancements in sequencing technologies and bioinformatics. This review examines the opportunities and challenges presented by genetic screening in the context of the rapidly evolving landscape of genomics. We discuss the expanding applications of genetic screening, from prenatal testing to population-wide initiatives, and the implications for healthcare, including disease prevention and personalized medicine. Additionally, we explore the ethical, legal, and social considerations surrounding genetic screening, emphasizing the need for informed decision-making and equitable access to genetic services. By analyzing recent research and emerging trends, this review provides insights into the future directions of genetic screening and its role in shaping healthcare policies and practices.